TSH Elevated in 6 Percent of Psychiatrically Hospitalized Youth
WEDNESDAY, Aug. 14, 2019 -- About 6 percent of psychiatrically hospitalized youth have abnormal thyroid-stimulating hormone (TSH) measures, according to a study published online Aug. 6 in the Journal of Clinical Psychiatry.
Marissa J. Luft, from the University of Cincinnati, and colleagues conducted a retrospective examination of screening TSH concentrations in 1,017 psychiatrically hospitalized children and adolescents (aged 3 to 19 years) with mood/anxiety disorders. Symptoms were extracted from medical records using adaptive natural language processing algorithms.
The researchers found that 62 patients had a TSH concentration >3.74 µlU/mL (5.3 percent of patients <12 years and 6.2 percent of patients ≥12 years) and seven had a TSH concentration <0.36 µlU/mL. There were correlations for elevated TSH concentration with recent weight gain, history of thyroid disease, abnormal menstrual bleeding/menometrorrhagia, and benzodiazepine treatment (odds ratios, 3.60, 6.88, 2.03, and 2.29, respectively). No correlations were noted for sex, age, or body mass index z score. Overall, 12.9 percent of patients with elevated TSH measures had an abnormal free/total thyroxine level or other biochemical findings consistent with thyroid disease.
"Despite being a routine screening test in pediatric patients at the time of psychiatric admission, the prevalence of thyroid disorders is poorly characterized in pediatric populations, and there is conflicting evidence on the utility of thyroid function screening in patients with severe mood and anxiety disorders," the authors write.
Two authors disclosed financial ties to the biopharmaceutical and publishing industries.
© 2020 HealthDay. All rights reserved.
Posted: August 2019
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.